Veracyte
VCYT
$20.35
Share price
0.79%
Change (1 day)
-5.44%
Change (1 year)
Categories
Earnings for Veracyte (VCYT)
Earnings in 2023 (TTM): -$76.6 M
According to Veracyte's latest financial reports the company's current earnings (TTM) are -$76.6 M. In 2022 the company made an earning of -$36.23 M an increase over its 2021 earnings that were of -$81.41 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Veracyte from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$76.6 M | 111.42% |
| 2022 | -$36.23 M | -55.5% |
| 2021 | -$81.41 M | 134.74% |
| 2020 | -$34.68 M | 190.89% |
| 2019 | -$11.93 M | -43.33% |
| 2018 | -$21.04 M | -23.78% |
| 2017 | -$27.6 M | -3.51% |
| 2016 | -$28.61 M | -14.17% |
| 2015 | -$33.33 M | 15.17% |
| 2014 | -$28.94 M | 14.15% |
| 2013 | -$25.35 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | -$0.18 B | 131.68% | 🇺🇸 USA |
 Myriad Genetics MYGN | -$0.26 B | 238.52% | 🇺🇸 USA |
 Biocept
BIOC | -$34.97 M | -54.35% | 🇺🇸 USA |